These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6807206)

  • 21. Enhanced proteolytic degradation of normal beta-galactosidase in the lysosomal storage disease with combined beta-galactosidase and neuraminidase deficiency.
    van Diggelen OP; Hoogeveen AT; Smith PJ; Reuser AJ; Galjaard H
    Biochim Biophys Acta; 1982 Apr; 703(1):69-76. PubMed ID: 6803839
    [No Abstract]   [Full Text] [Related]  

  • 22. A capillary electrophoretic study on the specificity of beta-galactosidases from Aspergillus oryzae, Escherichia coli, Streptococcus pneumoniae, and Canavalia ensiformis (jack bean).
    Zeleny R; Altmann F; Praznik W
    Anal Biochem; 1997 Mar; 246(1):96-101. PubMed ID: 9056188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Physicochemical and enzymatic properties of Aspergillus oryzae aminopeptidase].
    Verbilenko SV; Kolodzeiskaia MV
    Ukr Biokhim Zh (1978); 1980; 52(3):329-34. PubMed ID: 7385381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The crystal structure of acidic β-galactosidase from Aspergillus oryzae.
    Maksimainen MM; Lampio A; Mertanen M; Turunen O; Rouvinen J
    Int J Biol Macromol; 2013 Sep; 60():109-15. PubMed ID: 23688418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational design of the beta-galactosidase from Aspergillus oryzae to improve galactooligosaccharide production.
    Gao X; Wu J; Wu D
    Food Chem; 2019 Jul; 286():362-367. PubMed ID: 30827619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galacto configured N-aminoaziridines: a new type of irreversible inhibitor of β-galactosidases.
    Alcaide A; Trapero A; Pérez Y; Llebaria A
    Org Biomol Chem; 2015 May; 13(20):5690-7. PubMed ID: 25895752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and characterization of endo-beta-N-acetylglucosaminidase of Aspergillus oryzae.
    Hitomi J; Murakami Y; Saitoh F; Shigemitsu N; Yamaguchi H
    J Biochem; 1985 Aug; 98(2):527-33. PubMed ID: 3934149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingolipid beta-D-galactosidases in globoid cell leukodystrophy (Krabbe disease).
    Awasthi YC; Lund HW; Lo JT; Srivastava SK
    Birth Defects Orig Artic Ser; 1978; 14(6B):113-26. PubMed ID: 103589
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhanced β-galactosidase production of Aspergillus oryzae mutated by UV and LiCl.
    Zhang W; Liu F; Yang M; Liang Q; Zhang Y; Ai D; An Z
    Prep Biochem Biotechnol; 2014; 44(3):310-20. PubMed ID: 24274018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate specificity and distribution of acid beta-galactosidase activities in seizure-susceptible and non-susceptible strains of mice.
    Wheeler DF; Bachelard HS
    Neurochem Res; 1984 Jun; 9(6):849-62. PubMed ID: 6436723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biosynthesis of beta-fructofuranosidase by fungi of the genus Aspergillus].
    Dobrolinskaia GM; Serova InZ
    Prikl Biokhim Mikrobiol; 1974; 10(5):717-20. PubMed ID: 4463361
    [No Abstract]   [Full Text] [Related]  

  • 32. Kinetic characterization of galacto-oligosaccharide (GOS) synthesis by three commercially important β-galactosidases.
    Warmerdam A; Zisopoulos FK; Boom RM; Janssen AE
    Biotechnol Prog; 2014; 30(1):38-47. PubMed ID: 24124064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human beta-galactosidases: molecular and clinical aspects.
    Rittmann LS; O'Brien JS
    Isozymes Curr Top Biol Med Res; 1981; 5():77-113. PubMed ID: 6799421
    [No Abstract]   [Full Text] [Related]  

  • 34. [Nuclease from Aspergillus oryzae, specific for single-stranded regions of nucleic acids].
    Abramov RE; Bezirdzhian KhO; Akopian ZhI
    Biokhimiia; 1979 Jun; 44(6):990-5. PubMed ID: 465607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An efficient two step purification and molecular characterization of beta-galactosidases from Aspergillus oryzae.
    Todorova-Balvay D; Stoilova I; Gargova S; Vijayalakshmi MA
    J Mol Recognit; 2006; 19(4):299-304. PubMed ID: 16865665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ganglioside GM1 elevation in DBA/2 mouse embryos.
    Bouvier JD; Seyfried TN
    Dev Neurosci; 1990; 12(2):126-32. PubMed ID: 2110523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of thiol protease inhibitors on intracellular degradation of exogenous beta-galactosidase in cultured human skin fibroblasts.
    Ko YM; Yamanaka T; Umeda M; Suzuki Y
    Exp Cell Res; 1983 Oct; 148(2):525-9. PubMed ID: 6414834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S1 nuclease of Aspergillus oryzae: characterization of the associated phosphomonoesterase activity.
    Oleson AE; Hoganson ED
    Arch Biochem Biophys; 1981 Oct; 211(1):478-84. PubMed ID: 6272646
    [No Abstract]   [Full Text] [Related]  

  • 39. Immobilization of enzymes on spongy polyvinyl alcohol cryogels: the example of beta-galactosidase from Aspergillus oryzae.
    Rossi A; Morana A; Lernia ID; Di tombrino A; De Rosa M
    Ital J Biochem; 1999 Jun; 48(2):91-7. PubMed ID: 10434188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of galacto-oligosaccharides by β-galactosidase from Aspergillus oryzae using partially dissolved and supersaturated solution of lactose.
    Vera C; Guerrero C; Conejeros R; Illanes A
    Enzyme Microb Technol; 2012 Mar; 50(3):188-94. PubMed ID: 22305174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.